UPDATED Sep 28, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDL | US$2.33 | -5.7% | 13.1% | US$599.6m | US$4.76 | PB0.8x | E162.8% | n/a | ||
SBFM | US$1.46 | -3.3% | -54.1% | US$6.7m | US$7.00 | PB0.3x | E147.7% | n/a | ||
TLRY | US$1.15 | -4.2% | -34.7% | US$1.3b | n/a | PS1.6x | E141.3% | n/a | ||
MIRA | US$1.32 | -0.8% | 1.5% | US$25.2m | US$17.75 | PB44.2x | E112.8% | n/a | ||
EVOK | US$4.90 | -4.3% | 2.9% | US$10.2m | US$18.00 | PB2.3x | E110.9% | n/a | ||
ORGO | US$4.10 | -13.1% | 43.4% | US$520.1m | US$8.00 | PS1.2x | E109.0% | n/a | ||
AZTA | US$28.56 | -9.0% | -41.0% | US$1.3b | US$33.00 | PS2x | E102.2% | 0% | ||
HBIO | US$0.44 | -6.9% | -83.5% | US$19.8m | US$2.00 | PB1.3x | E98.7% | n/a | ||
PLX | US$2.06 | 1.0% | 102.0% | US$164.2m | US$14.00 | PE26.2x | E88.4% | n/a | ||
EXAS | US$53.57 | 0.02% | -21.4% | US$10.1b | US$64.65 | PS3.4x | E84.8% | n/a | ||
AMRN | US$16.00 | 4.1% | 27.6% | US$330.9m | US$11.00 | PS1.5x | E83.2% | n/a | ||
AMRX | US$9.75 | -2.5% | 17.2% | US$3.1b | US$12.50 | PE907.3x | E80.6% | 0% | ||
CAI | US$29.19 | -11.4% | n/a | US$8.2b | US$39.38 | PS15.4x | E80.2% | n/a | ||
VTRS | US$9.52 | -2.8% | -18.0% | US$11.1b | US$11.43 | PB0.7x | E77.9% | 5.0% | ||
MYGN | US$7.70 | -1.8% | -71.9% | US$716.4m | US$7.50 | PB1.8x | E77.6% | n/a | ||
OCGN | US$1.46 | 5.0% | 47.1% | US$456.0m | US$6.50 | PS95.9x | E76.9% | n/a | ||
ALDX | US$5.07 | 2.4% | -5.9% | US$304.4m | US$9.50 | PB5.5x | E74.8% | n/a | ||
ITRM | US$0.72 | 5.9% | -34.0% | US$32.1m | US$7.00 | PE-1.3x | E74.8% | n/a | ||
MDXH | US$4.63 | -1.1% | 122.6% | US$229.2m | US$6.04 | PS2.3x | E74.6% | n/a | ||
BRTX | US$1.43 | -3.4% | -17.8% | US$11.4m | US$13.00 | PS18.9x | E74.2% | n/a | ||
OMER | US$4.46 | 3.7% | 12.3% | US$303.5m | US$22.50 | PE-2.2x | E73.5% | n/a | ||
CLGN | US$3.14 | 26.0% | -36.8% | US$39.9m | US$11.56 | PS16.6x | E72.6% | n/a | ||
APRE | US$1.46 | -0.7% | -46.9% | US$8.5m | US$10.50 | PS10.1x | E72.0% | n/a | ||
CLNN | US$5.88 | -8.1% | 28.1% | US$59.2m | US$30.43 | PS207x | E72.0% | n/a |